Eli Lilly (LLY)

The bulls took charge Wednesday after the Federal Reserve said it would taper its asset purchases by March and signaled three rate hikes in 2022.

Large-cap pharmaceutical stocks offer investors stable, substantial dividends, regardless of market conditions. Here are nine that stand out.

Treasury rates stabilized Wednesday, giving stocks some breathing room, but a modest comeback still wobbled into the finish.

The S&P 500 set yet another new all-time high Tuesday as investors refused to hit the panic button over resurgent COVID caseloads.

Billionaires and high-asset hedge funds have done lots of selling in 2021. Here are 25 stocks they unloaded in the first three months of the year.

Small caps enjoyed an explosive pop Monday, helped by a coalition of meme stocks and innovative growth plays, but blue chips recorded a more modest fi…

A violent rotation from tech and other growth stocks, and into value names, continued Tuesday as a COVID drug received an emergency-use green light.

Johnson & Johnson (JNJ) paused a vaccine study, and Eli Lilly (LLY) was forced to do the same on a treatment trial, hampering stocks Tuesday.